ArticleMediterranean journal of hematology and infectious diseases2013
Sphingomonas paucimobilis infections in children: 24 case reports.
Article in Mediterranean journal of hematology and infectious diseases, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 41 citations in OpenAlex.
- Alterations of the paired maternal fecal microbiota and neonatal meconium microbiota in newborns from pregnant women with hypertensive disorders.Frontiers in microbiology · 2025Article
- Isolation ofClinical case reports · 2023Article
- ConcurrentMedicina (Kaunas, Lithuania) · 2023Review
- Multi-omic approach to decipher the impact of skincare products with pre/postbiotics on skin microbiome and metabolome.Frontiers in medicine · 2023Article
- First Case Report of Sphingobium lactosutens as a Human Pathogen Causing Peritoneal Dialysis-Related Peritonitis.Cureus · 2022Article
- The Gram-Negative Bacilli Isolated from Caves-International journal of environmental research and public health · 2022Review
- Toys in the Playrooms of Children's Hospitals: A Potential Source of Nosocomial Bacterial Infections?Children (Basel, Switzerland) · 2021Article
- Evaluation ofIranian journal of microbiology · 2021Article
- Altered Microbial Composition of Drug-Sensitive and Drug-Resistant TB Patients Compared with Healthy Volunteers.Microorganisms · 2021Article
- A Rare Case of Sphingomonas paucimobilis Spondylodiscitis Managed Surgically.Journal of orthopaedic case reports · 2021Article
- Occurrence of Antibiotic-Resistant Bacteria in Therapy Pools and Surrounding Surfaces.International journal of environmental research and public health · 2018Article
- First report of Sphingomonas koreensis as a human pathogen in a patient with meningitis.Journal of clinical microbiology · 2015Article
- In silico detection of virulence gene homologues in the human pathogen sphingomonas spp.Evolutionary bioinformatics online · 2014Article
- Community Acquired Bacteremia by Sphingomonas paucimobilis: Two Rare Case Reports.Journal of clinical and diagnostic research : JCDR · 2013Article
- Otomastoiditis caused byAutopsy & case reportsArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 3 institutions in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sphingomonas paucimobilis is a causative agent of infection in immunocompromised patients, and healthcare-associated infection. Although the infections associated with S.paucimobilis occurs rarely, it has been encountered with increasing frequency in clinical settings. In the current study we reported clinical features of the children with S.paucimobilis infection, and the antimicrobial susceptibilities of the isolated strains among the patients. This study was conducted in Dr. Behçet Uz Children's Hospital, Turkey, during the period of January 2005 and December 2012. The medical records of pediatric patients with positive cultures for S.paucimobilis were reviewed. Sphingomonas paucimobilis isolates were recovered from 24 pediatric patients. The median age was 4 years (ranging from 3 days infant to 15 years) and 58,3% were male. Eight (33,3%) of the patients were under 1 months of age. Among the patients; 13 (54,2%) infections were community related however 11(45.8%) infections were nosocomial infection. The median duration of hospital stay was 7 days (ranging from 4 to 22 days). The most effective antibiotics were fluoroquinolones, carbapenems, and trimethoprim/sulfamethoxazole. This is the first largest study in children to evaluate the clinical features of S. paucimobilis infections. Sphingomonas paucimobilis may cause infections in both previously healthy and immunocompromised children. Although variable antimicrobial regimens were achieved to the patients, there was no attributable fatality due to S.paucimobilis infections due to the low virulence of the bacteria.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.